Key Events This Week
7 Sep: Robust trading activity with upgraded Mojo Grade to Buy
8 Sep: Technical momentum shifts to bullish amid strong returns
9-11 Sep: Price consolidation with minor declines but overall weekly gain
Sep 18, 03:30 PM
BSE+NSE Vol: 6.29 lacs

Wockhardt Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a 2.03% decline in the latest trading session, key technical indicators such as MACD, moving averages, and Bollinger Bands suggest strengthening upward momentum, while some oscillators present mixed signals. This nuanced technical landscape offers investors a complex but promising outlook amid broader market volatility.
Read full news article
Wockhardt Ltd’s investment rating has been downgraded from Buy to Hold as of 15 Sep 2026, reflecting a nuanced reassessment across quality, valuation, financial trends, and technical indicators. Despite robust recent financial performance and strong long-term returns, concerns over valuation metrics, debt servicing ability, and a shift in technical momentum have tempered enthusiasm among analysts.
Read full news article
Wockhardt Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish stance as of mid-September 2026. Despite a significant day decline of 5.41%, the pharmaceutical company’s longer-term technical indicators present a complex picture, with mixed signals across weekly and monthly charts. This article analyses the recent technical parameter changes, key momentum indicators, and the implications for investors navigating the Pharmaceuticals & Biotechnology sector.
Read full news article
7 Sep: Robust trading activity with upgraded Mojo Grade to Buy
8 Sep: Technical momentum shifts to bullish amid strong returns
9-11 Sep: Price consolidation with minor declines but overall weekly gain

Wockhardt Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. The pharmaceutical company’s robust quarterly results, impressive stock returns, and improved technical outlook have collectively driven this positive revision, signalling renewed investor confidence in its growth prospects.
Read full news article
Wockhardt Ltd has demonstrated a significant shift in technical momentum, upgrading from a mildly bullish to a bullish trend, supported by robust price action and positive signals from key technical indicators. The pharmaceutical and biotechnology small-cap stock has outperformed the broader market substantially, reflecting renewed investor confidence and a favourable outlook.
Read full news article
Wockhardt Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most actively traded stocks by value on 7 September 2026. The stock demonstrated significant strength with a 4.43% gain on the day, supported by robust volume and institutional participation, signalling renewed investor confidence and a positive shift in market sentiment.
Read full news article
The Sensex advanced 0.7% on 4 Sep 2026, yet Wockhardt Ltd outpaced the broader market with a robust 7.12% gain, reaching an intraday high of Rs 2090. This 7.48-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
Wockhardt Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 August 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 03 September 2026, providing investors with the most up-to-date view of the company’s performance and outlook.
Read full news articlePursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI (LODR) Regulations 2015 we enclose herewith a copy of newspaper advertisement published today i.e. 25th August 2026 regarding the opening of special window for re-lodgment of transfer requests of shares held in physical form
Pursuant to Regulation 30 (read with Part A of Schedule III) of SEBI (LODR) Regulations 2015 we wish to inform you that the Company is in receipt of an Adjudication Order passed by Commissioner of Customs Nhava Sheva-II JNCH.
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (LODR) Regulations 2015 the Proceedings of the 27th AGM of the Company
No Upcoming Board Meetings
Wockhardt Ltd has declared 200% dividend, ex-date: 17 Nov 16
No Splits history available
No Bonus history available
Wockhardt Ltd has announced 3:10 rights issue, ex-date: 08 Mar 22